A recent paper identified the DNA double-strand break signaling kinase ataxia-telangiectasia mutated (ATM) and its downstream target checkpoint kinase 2 (Chk2) as regulators of Aurora B recruitment to the midbody center in human cancer cells [81]. This evidence concerns the gene ATM and cancer.